rhG-CSF does not affect the phenotype of adult donor peripheral blood NK cells

Bone Marrow Transplantation

Volumn 35, Issue 1, 2005, Pages 25-32

  Lassailly, F ^a,b   Sielleur, I ^a,b   Blaise, D ^a,b   Chabannon, C ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

Allogeneic transplantation; Natural cytotoxicity receptors; Natural killer cells; Natural killer receptors

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; APHERESIS; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; TUMOR CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD3; ANTIGENS, CD56; BLOOD DONORS; BONE MARROW CELLS; FETAL BLOOD; FLOW CYTOMETRY; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; NEOPLASMS; PHENOTYPE; RECEPTORS, IGG; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 11844290652     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704711     Document Type: Article

References (42)

1. Gratwohl A, Baldomero H, Passweg J et al. Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 2003; 17: 941-959.
2. Maraninchi D, Gluckman E, Blaise D et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet 1987; 2: 175-178.
3. Asai O, Longo DL, Tian ZG et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998; 101: 1835-1842.
4. Ruggeri L, Capanni M, Casucci M et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333-339.
5. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097-2100.
6. Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002; 100: 3825-3827.
7. Giebel S, Locatelli F, Lamparelli T et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814-819.
8. Lowe EJ, Turner V, Handgretinger R et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol 2003; 123: 323-326.
9. Moretta A, Vitale M, Bottino C et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993; 178: 597-604.
10. Ciccone E, Pende D, Viale O et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992; 176: 963-971.
11. Mandelboim O, Lieberman N, Lev M et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409: 1055-1060.
12. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727-729.
13. Salih HR, Antropius H, Gieseke F et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003; 102: 1389-1396.
14. Cooper MA, Fehniger TA, Turner SC et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 (bright) subset. Blood 2001; 97: 3146 3151.
15. Andre P, Spertini O, Guia S et al. Modification of P-selectin glycoprotein ligand- 1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci USA 2000; 97: 3400-3405.
16. Mohty M, Kuentz M, Michallet M et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 2002; 100: 3128-3134.
17. Ringden O, Labopin M, Bacigalupo A et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia, J Clin Oncol 2002; 20 4655-4664.
18. Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685-3691.
19. Gyger M, Stuart RK, Perreault C. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor. Bone Marrow Transplant 2000; 26: 1-16.
20. Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997; 90: 3098-3105.
21. Mielcarek M, Graf L, Johnson G, Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998; 92: 215-222.
22. Rondelli D, Raspadori D, Anasetti C et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 1998; 22: 631-637.
23. Tayebi H, Kuttler F, Saas P et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 2001; 29: 458-470.
24. Joshi SS, Lynch JC, Pavletic SZ et al. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 2001; 98: 1963-1970.
25. Pascal V, Brunet C, Pradel V et al. Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation. Leukemia 2002; 16: 2259-2266.
26. Olivero S, Novakovitch G, Ladaique P et al. T-cell depletion of allogeneic bone marrow grafts: enrichment of mononuclear cells using the COBE Spectra cell processor, followed by immunoselection of CD34 + cells. Cytotherapy 1999; 1: 469-477.
27. Spaggiari GM, Carosio R, Pende D et al. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol 2001; 31: 1656-1665.
28. Hayakawa Y, Takeda K, Yagita H et al. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur J Immunol 2001; 31: 1720-1727.
29. Sica S, Rutella S, Di Mario A et al. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. J Hematother 1996; 5: 391-397.
30. Martinez C, Urbano-Ispizua A, Rozman C et al. Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol 1996; 72: 269-272.
31. Joshi SS, Lynch JC, Pavletic SZ et al. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 2001; 98: 1963-1970.
32. Gurman G, Dilek I, Arslan O et al. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Transfus Apheresis Sci 2001; 24: 23-28.
33. Trzonkowski P, Zaucha JM, Mysliwska J et al. Differences in kinetics of donor lymphoid cells in response to G-CSF administration may affect the incidence and severity of acute GvHD in respective HLA-identical sibling recipients. Med Oncol 2004; 21 81-94.
34. Silva MR, Parreira A, Ascensao JL. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion. Exp Hematol 1995; 23 1676-1681.
35. Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997; 90: 3098-3105.
36. Rondelli D, Raspadori D, Anasetti C et al. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 1998; 22: 631-637.
37. Gazitt Y. Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors. Stem Cells 2000; 18: 390-398.
38. Gazitt Y, Shaughnessy P, Devore P. Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors. J Hematother Stem Cell Res 2001; 10 177-186.
39. Tayebi H, Kuttler F, Saas P et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 2001; 29: 458-470.
40. Durek C, Schafer I, Braasch H et al. Effects of colony-stimulating factors on cellular cytotoxicity. Cancer Immunol Immunother 1997; 44: 35-40.
41. Taga T, Kariya Y, Shimada M, Uchida A. Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: role of granulocyte colony-stimulating factor. Immunol Lett 1993; 39: 65-70.
42. Takenaka K, Mizuno SI, Harada M et al. Generation of human natural killer cells from peripheral blood CD34 + cells mobilized by granulocyte colony-stimulating factor. Br J Haematol 1996; 92 788-794.